Search

everythinglearnresearchcommunity

for

Search:↓

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Non-obese women with hair loss have higher heart disease risk.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Right hand finger ratio may predict male hair loss.

Finger length ratio may indicate male hair loss.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Scalp reduction surgery is safe and effective for certain patients with hair loss, leading to dense hair coverage and high satisfaction.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Estetrol (E4) may help treat female pattern hair loss by prolonging hair growth.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.